Outcome
|
Studies
|
Participants
|
Statistical Method
|
Effect Estimate
|
P value
|
Homogeneity(I2)
|
P value
|
---|
DOR
|
A vs. O
|
9
|
35,156
|
RR (M-H, Random, 95%CI)
|
0.98[0.85,1.13]
|
0.80
|
85%
|
< 0.00001
|
B vs. O
|
8
|
34,296
|
RR (M-H, Random, 95%CI)
|
0.96[0.76,1.20]
|
0.71
|
91%
|
< 0.00001
|
AB vs. O
|
8
|
23,407
|
RR (M-H, Random, 95%CI)
|
1.00[0.76,1.30]
|
0.98
|
84%
|
< 0.00001
|
Non-O vs. O
|
9
|
35,163
|
RR (M-H, Random, 95%CI)
|
0.94[0.79,1.11]
|
0.43
|
92%
|
< 0.00001
|
OHSS
|
A vs. O
|
2
|
1217
|
RR (M-H, Fixed, 95%CI)
|
1.05[0.66,1.66]
|
0.85
|
0%
|
0.58
|
B vs. O
|
2
|
829
|
RR (M-H, Fixed, 95%CI)
|
1.04[0.46,2.35]
|
0.92
|
0%
|
0.44
|
AB vs. O
|
2
|
734
|
RR (M-H, Fixed, 95%CI)
|
0.51[0.10,2.56]
|
0.42
|
0%
|
0.75
|
Non-O vs. O
|
2
|
1408
|
RR (M-H, Fixed, 95%CI)
|
1.02[0.65,1.57]
|
0.95
|
0%
|
0.54
|
LBR
|
A vs. O
|
3
|
4882
|
RR (M-H, Random, 95%CI)
|
1.27[0.74,2.17]
|
0.38
|
97%
|
< 0.00001
|
B vs. O
|
3
|
3493
|
RR (M-H, Random, 95%CI)
|
1.47[0.95,2.29]
|
0.09
|
88%
|
0.0002
|
AB vs. O
|
3
|
3291
|
RR (M-H, Random, 95%CI)
|
1.48[0.76,2.90]
|
0.25
|
94%
|
< 0.00001
|
Non-O vs. O
|
4
|
6341
|
RR (M-H, Random, 95%CI)
|
1.28[0.83,1.98]
|
0.27
|
96%
|
< 0.00001
|
CPR
|
A vs. O
|
2
|
1965
|
RR (M-H, Random, 95%CI)
|
1.12[0.90,1.38]
|
0.31
|
61%
|
0.11
|
B vs. O
|
2
|
1194
|
RR (M-H, Fixed, 95%CI)
|
1.08[0.89,1.30]
|
0.43
|
0%
|
0.99
|
AB vs. O
|
2
|
1266
|
RR (M-H, Fixed, 95%CI)
|
1.05[0.90,1.24]
|
0.52
|
17%
|
0.27
|
Non-O vs. O
|
3
|
2886
|
RR (M-H, Fixed, 95%CI)
|
1.05[0.96,1.15]
|
0.27
|
8%
|
0.34
|
MR
|
Non-O vs. O
|
2
|
2386
|
RR (M-H, Fixed, 95%CI)
|
0.94[0.76,1.18]
|
0.62
|
0%
|
0.33
|
- Note: DOR Diminished ovarian reserve; OHSS Ovarian hyperstimulation syndrome; CPR Clinical pregnancy rate; LBR Live birth rate; MR Miscarriage rate; RR Risk ratio